The emerging role of GLP-1 receptor agonists in treating or preventing cancer.

Benjamin DJ, Von Hoff DD

DOI: 10.20517/cdr.2024.116
Published: 2024
Container: Cancer drug resistance (Alhambra, Calif.)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.20517/cdr.2024.116,
  title = {The emerging role of GLP-1 receptor agonists in treating or preventing cancer.},
  author = {Benjamin DJ and Von Hoff DD},
  year = {2024},
  journal = {Cancer drug resistance (Alhambra, Calif.)},
  doi = {10.20517/cdr.2024.116},
  url = {https://doi.org/10.20517/cdr.2024.116}
}

RIS

TY  - JOUR
TI  - The emerging role of GLP-1 receptor agonists in treating or preventing cancer.
AU  - Benjamin DJ
AU  - Von Hoff DD
PY  - 2024
JO  - Cancer drug resistance (Alhambra, Calif.)
DO  - 10.20517/cdr.2024.116
UR  - https://doi.org/10.20517/cdr.2024.116
ER  -

APA

DJ, B., & DD, V. H. (2024). The emerging role of GLP-1 receptor agonists in treating or preventing cancer.. Cancer drug resistance (Alhambra, Calif.). https://doi.org/10.20517/cdr.2024.116

Source records

pubmed · retrieved 2026-09-27T00:08:13.708Z